Ohnmacht, Alexander J.
Stahler, Arndt
Stintzing, Sebastian http://orcid.org/0000-0002-3297-5801
Modest, Dominik P. http://orcid.org/0000-0002-6853-0599
Holch, Julian W.
Westphalen, C. Benedikt http://orcid.org/0000-0002-5310-3754
Hölzel, Linus
Schübel, Marisa K.
Galhoz, Ana
Farnoud, Ali
Ud-Dean, Minhaz
Vehling-Kaiser, Ursula
Decker, Thomas
Moehler, Markus
Heinig, Matthias
Heinemann, Volker
Menden, Michael P. http://orcid.org/0000-0003-0267-5792
Funding for this research was provided by:
EC | Horizon 2020 Framework Programme (950293)
Merck KGaA
Pfizer
Almac Group
Roche
Article History
Received: 4 March 2022
Accepted: 17 August 2023
First Online: 4 September 2023
Competing interests
: A.S. served on advisory boards for BMS and Novocure, received honoraria for talks by Roche, Servier and Taiho Pharmaceuticals and received reimbursement for travel by Roche, Merck KGaA, MSD Sharp & Dohme, Pfizer, Lilly Oncology, and Amgen. V.H., S.S. and D.P.M. received honoraria for talks, advisory boards and travel expenses by Merck KGaA, Amgen, Roche, Pfizer, BMS, MSD, AstraZeneca, Novartis, Terumo, Oncosil, Nordic, Seagen, GSK, Takeda, Servier, Pierre Fabre, Taiho, Lilly Oncology, Servier, Sanofi and Bayer Pharmaceuticals. M.P.M. is a former employee at AstraZeneca, academically collaborates with AstraZeneca, GSK and Roche, and receives funding from GSK and Roche. J.W.H. served on an advisory board for Roche, has received honoraria from Roche, and travel support from Novartis. M.M. received honoraria for advisory boards or talks by Amgen, BMS, Roche, Merck KGaA, MSD Sharp & Dohme, Lilly Oncology, Servier, Pierre Fabre, Taiho Sanofi and Bayer Pharmaceuticals and serves as officer for the European Organisation on Research and Treatment of Cancer (EORTC), and Arbeitsgemeinschaft internistische Onkologie (AIO). C.B.W. has received honoraria from Amgen, Bayer, Chugai, Celgene, GSK, MSD, Merck, Janssen, Ipsen, Roche, Servier, SIRTeX, Taiho; served on advisory boards for Bayer, BMS, Celgene, Servier, Shire/Baxalta, Rafael Pharmaceuticals, RedHill, Roche, has received travel support by Bayer, Celgene, RedHill, Roche, Servier, Taiho and research grants (institutional) by Roche. C.B.W. serves as an officer for the European Society of Medical Oncology (ESMO), Deutsche Krebshilfe (DKH) and AIO. The remaining authors declare no competing interests.